Baumer

Baumer Net Margin

The Net Profit Margin of Baumer (BALM4.SA) as of Nov 10, 2026 is 16.49 %. In the previous year, Net Profit Margin was 5.41 % — a change of 205.13% (higher).

Net Margin

16.49 %

YoY

205.13%

Last updated:

Net Profit Margin of Baumer is 2024 16.49 % . Net Profit Margin of Baumer was 2023 5.41 % . It decreases by 205.13% higher compared to the previous year.

Baumer's net margin stands at 16.5%, up from 10.5% several years earlier.

The Baumer Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2017
0.62 BRL
Jan 1, 2018
2.30 BRL
Jan 1, 2019
4.19 BRL
Jan 1, 2020
10.45 BRL
Jan 1, 2021
11.93 BRL
Jan 1, 2022
3.49 BRL
Jan 1, 2023
5.41 BRL
Jan 1, 2024
16.49 BRL
The Baumer Net Margin history
YEARNet MarginYoY
16.49 %+205.13%
5.41 %+55.10%
3.49 %-70.79%
11.93 %+14.18%
10.45 %+149.59%
4.19 %+82.22%
2.30 %+273.64%
0.62 %-76.94%
2.67 %-78.83%
12.59 %+27.40%
9.89 %+8,103.03%
0.12 %+41.36%
0.09 %+15.53%
0.07 %+149.85%
0.03 %+4.85%
0.03 %-50.30%
0.06 %+105.62%
0.03 %-66.77%
0.08 %+9.05%
0.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Net Profit Margin of Baumer is 16.49 % in 2024.

Net Profit Margin of Baumer changed from 5.41 % to 16.49 %, representing a 205.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Baumer since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Baumer with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Baumer

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Baumer